title: Thermal enhancement of ACNU and potentiation of thermochemotherapy with ACNU by hypertonic glucose in the BT4An rat glioma.
abstract: Hyperthermia increases the cytotoxicity of the nitrosourea BCNU (carmustine). Glucose given before treatment may further increase the value of thermochemotherapy, presumably by lowering tumour pH through blood flow reduction. The water-soluble ACNU (nimustine) is an alternative to other nitrosoureas in the treatment of gliomas. The drug is soluble without use of ethanol, and the eye complications when given intra-arterially are reduced compared with similar use of BCNU. The influence of simultaneous hyperthermia on treatment with ACNU, and the value of glucose administered before thermochemotherapy therefore were investigated in the malignant rat glioma BT4An. BD IX rats with subcutaneous BT4An tumours on the hind leg were treated with ACNU (i.p.), or ACNU and locally applied waterbath hyperthermia (44 degrees C for 45 min), with or without previous glucose (6 g/kg i.p. 2 hours before treatment). ACNU (10 or 20 mg/kg) alone and ACNU (20 mg/kg) after previous glucose did not influence tumour growth, compared to the controls. Simultaneous ACNU (10 mg/kg) and hyperthermia clearly was more effective than treatment with hyperthermia alone. Glucose load before treatment further enhanced the effect of combined ACNU and hyperthermia. Glucose before treatment did not change local toxicity or weight profiles of treatment with ACNU alone, or simultaneous ACNU and hyperthermia. Glucose load therefore represented a therapeutic gain when administered before thermochemotherapy with ACNU.
authors.affiliation: Department of Oncology, Haukeland Hospital, University of Bergen, Norway.
authors.forename: B C
authors.initials: BC
authors.lastname: Schem
authors.forename: O
authors.initials: O
authors.lastname: Dahl
mesh_terms: D000818:Animals; D001932:Brain Neoplasms; D002330:Carmustine / Q000627:therapeutic use / Q000633:toxicity; D003131:Combined Modality Therapy; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D005910:Glioma / Q000188:drug therapy / Q000628:therapy*; D005947:Glucose / Q000008:administration & dosage* / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D006979:Hyperthermia, Induced; D006982:Hypertonic Solutions / Q000008:administration & dosage / Q000494:pharmacology; D009368:Neoplasm Transplantation; D015376:Nimustine / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D012164:Retinal Diseases / Q000139:chemically induced; D012878:Skin Neoplasms / Q000188:drug therapy / Q000628:therapy; D014407:Tumor Cells, Cultured / Q000637:transplantation
chemical_list: D006982:Hypertonic Solutions; D015376:Nimustine; D005947:Glucose; D002330:Carmustine